SYNDAX PHARMACEUTICALS INC's ticker is and the CUSIP is 87164F905. A total of 4 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $893,055 | +8.8% | 43,500 | +26.1% | 0.00% | – |
| Q1 2024 | $821,100 | -65.3% | 34,500 | -68.5% | 0.00% | -100.0% |
| Q4 2023 | $2,366,295 | -48.8% | 109,500 | -65.6% | 0.00% | 0.0% |
| Q3 2023 | $4,624,620 | +1111.4% | 318,500 | +2023.3% | 0.00% | – |
| Q4 2022 | $381,750 | -0.1% | 15,000 | -5.7% | 0.00% | – |
| Q3 2022 | $382,000 | +29.1% | 15,900 | +3.2% | 0.00% | – |
| Q2 2022 | $296,000 | – | 15,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 157 | $137,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,400 | $47,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |